11␤-HSD1 in brain amplifies glucocorticoid concentrations locally. Data from knockout mice suggest that selective 11␤-HSD1 inhibitors may be useful in reducing the adverse effects of chronic glucocorticoid excess on age-associated memory impairments, despite altered circulating glucocorticoid levels. The enzyme is expressed in human brain but any role in stress-related psychiatric disorders such as anxiety and depression remains to be determined.
Metabotropic glutamate receptors on peripheral sensory neuron terminals as targets for the development of novel analgesics F Karim, G Bhave, RW Gereau
Group I metabotropic glutamate receptors (mGluRs1/5) have been implicated in nociceptive transmission in the central nervous system. The role of peripheral mGluRs1/5 in nociception has recently been investigated. Group I mGluRs are present on cutaneous terminals of nociceptive afferents and their activation induces hyperalgesia. Furthermore, local pre-or posttreatment with mGluR1/5-selective antagonists attenuates inflammatory and neuropathic pain hypersensitivity. These findings implicate peripheral group I mGluRs as safe therapeutic targets for pain.
HYPOTHESIS Eating behavior in anorexia nervosa-an excess of both orexigenic and anorexigenic signalling? A Inui
The most distinguishing characteristic of anorexia nervosa (AN) is severe emaciation. Weight loss is a potent stimulus to food intake in normal humans and animals. The persistence of anorexia, therefore, implies a failure of this adaptive feeding response which is observed in simple starvation. In AN, the excess of both orexigenic (feeding-stimulatory) and anorexigenic (feedinginhibitory) signalling appears to be characteristic, which may produce 'mixed' signals about satiety and desire for food. Improved understanding of disturbances of feeding-regulatory signals in AN may lead to more specific and effective pharmacologic interventions.
PERSPECTIVE
The other, forgotten genome: mitochondrial DNA and mental disorders T Kato Accomplishment of the human genome project makes us feel as if all human diseases can be explained by the nuclear genome. However, the authors remind us that the other genome, mitochondrial DNA (mtDNA), is also a source of many human diseases. This paper summarizes recent research suggesting the possible pathophysiological significance of mtDNA in mental disorders.
REVIEW ARTICLE

Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms BD Pearce
This review considers the evidence that prenatal or perinatal viral infections could be involved in schizophrenia pathogenesis. One intriguing hypothesis put forward is that certain viruses could disrupt the development of inhibitory neurons and hence set the stage for a slowly evolving excitotoxicity that could then entrain other neurons or circuits into a pathological cascade. Such a mechanism might pertain to the wellestablished variability between patients with regard to both symptoms and neuropathology. This review underscores the need to define the relationship between insults to the fetus or neonate, and the heterogeneous brain disease subsumed under the rubric of 'schizophrenia'.
MILLENNIUM ARTICLE
Neurobiology of the stress response early in life: evolution of a concept and the role of corticotropin releasing hormone KL Brunson, S Avishai-Eliner, CG Hatalski, TZ Baram Can the neonatal brain respond to stress? Over the last few decades, much work has contributed to the understanding of the means by which the mature brain reacts to potentially injurious signals ('stress'). Concurrently, concepts regarding the presence of brain-derived responses to stress during the neonatal and infancy periods have been evolving, in particular regarding the role of the brain-derived stress-hormone, corticotropin releasing hormone (CRH). This review discusses current knowledge about the functions of CRH in the reaction of the neonatal animal (or human) to both immediate as well as protracted stress. While responding to stress, the neonatal brain is also influenced by it. Early life stress may permanently modify the systems used by the organism to cope with further stressful stimuli, and recent data suggest that CRH may play an integral role in the mechanisms of these long-term changes.
ORIGINAL RESEARCH ARTICLES
Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex P Devoto, G Flore, L Pani, GL Gessa Most conditions that increase dopamine (DA) release in the prefrontal cortex (PFC), also increase noradrenaline (NA) release, suggesting that DA might be coreleased with NA from NA neurons. According to this hypothesis the authors found that extracellular DA concentration in the rat PFC is similar to that observed in cortical areas such as motor, occipital and cerebellar, which are almost devoid of DA projections. Moreover, ␣ 2 receptor ligands were found to modify in the same manner both extracellular NA and DA in PFC as in the other cortices, while D 2 receptor ligands, as well as gammabutyrolactone, are ineffective. The data indicate that extracellular DA in the PFC depends on the presence and activity of NA rather than DA neurons and suggest that DA acts not only as NA precursor but also as co-transmitter. They might explain why clozapine, risperidone, mianserine and mirtazapine that inhibit ␣ 2 receptors concomitantly increase NA and DA release in the PFC.
Intra-abdominal injection of double-stranded RNA into anesthetized adult Drosphila triggers RNA interference in the central nervous system S Dzitoyeva, N Dimitrijevic, H Manev RNA interference (RNAi) is a gene silencing mechanism triggered by double-stranded RNA (dsRNA) that corresponds to an endogenous mRNA and leads to its desctruction. RNAi can be used for functional genomics to study loss-of-functions phenotypes. With respect to the functioning of the central nervous system (CNS), RNAi should ideally be used without NCS development disturbances. Here, the authors show that RNAi can be induced in adult fruit flies by injecting dsRNA into the abdomen of anesthetized Drosophila, and that it can target genes expressed in the CNS; lacZ transgene (expressed either in the gut or in the CNS), and GM06434, the Drosophila homologue of the C. elegans gene Nrf (nose resistant to fluoxetine). Both genes were successfully silenced in adult Drosophila by intraabdominal injection of their respective dsRNA. The author's method of RNAi can be used to characterize gene functioning in the adult CNS without the typical interference in development found in gene mutation studies.
Screening ABCG1, the human homologue of the Drosophila white gene, for novel polymorphisms and association with bipolar affective disorder G Kirov, CA Lowry, M Stephens et al ABCG1 encodes a transporter protein that may be involved in the cellular uptake of tryptophan. Tryptophan is the precursor for serotonin, which is implicated in the regulation of mood. The gene maps to a region strongly implicated in bipolar disorder: chromosome 21q22.3. The authors screened all 15 exons and 700 bases of the 5′ flanking region of ABCG1. Several novel polymorphisms were identified, however none of them were in coding sequences. Thirteen polymorphisms were tested for association with bipolar affective disorder in a sample of 110 parent-offspring trios. No alleles or haplotypes were significantly preferentially transmitted. The polymorphisms identified in this study will be useful in examining the role of this gene in other neuropsychiatric disorders.
Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder I-S Yoon, PP Li, K-P Siu, JL Kennedy et al
Reduced inositol monophosphatase (IMPase) activity and elevated basal intracellular calcium levels have been reported in B lymphoblast cell lines (BLCLs) from bipolar I affective disorder (BD-I) patients. Using an RT-PCR assay, mRNA levels were estimated for IMPA1 and 2 genes encoding human IMPase 1 and 2, respectively, in BLCLs phenotyped on calcium from patients with a DSM-IV diagnosis of BD-I and from age-and sexmatched healthy subjects. IMPA2 mRNA levels were significantly lower in BLCLs from male BD-I patients with high calcium compared with healthy male subjects, male BD-I patients with normal BLCL and female BD-I patients with high calcium. A significant negative correlation was observed between IMPA2 mRNA levels and calcium in BLCLs from male but not female BD-I patients. Sex-dependent differences were also evident in postmortem temporal cortex IMPA2 mRNA levels which, in contrast to BLCLs, were significantly higher in male BD-I subjects compared with male controls. Collectively, these observations suggest a potential sexdependent link between abnormalities in IMPA2 expression and calcium homeostasis in the pathophysiology of BD.
A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes M Maziade, MA Roy, É Rouillard et al Although highly heritable, schizophrenia (SZ) and bipolar (BP) disorder are complex disorders. Twenty-one multigenerational pedigrees of Eastern Quebec, comprising 480 members, were screened for 18 candidate chromosomal areas, as a first stage of a two-stage genome scan. The authors also tested the hypothesis that some of these genes might be common to both disorders. Results provide support: (1) for susceptibility loci on chromosomes 18q and 6p, the former common to SZ and BP, the latter specific to SZ; (2) for weaker evidence for loci in 3q, 10p and 21q; (3) for the search of both specific and common susceptibility loci for SZ and BP.
Association of CAG repeat loci on Chromosome 22 with schizophrenia and bipolar disorder Q Saleem, D Dash, C Gandhi et al
Numerous linkage, cytogenetic and association studies have implicated regions on Chromosome 22 in bipolar disorder and schizophrenia. Recent evidence has also suggested that CAG repeat tract expansions play a role in these diseases. The authors sought to test the hypothesis that susceptibility loci for bipolar disorder and schizophrenia on this chromosome might contain expanded CAG repeats. Taking advantage of the recent availability of the complete sequence of Chr. 22 they created an integrated map of all CAG repeats Ͼ5 on this chromosome and loci previously implicated in these disorders. The authors then chose the longest repeat tracts, known to be expressed in the brain, and studied them in bipolar and schizophrenia patients using a case control approach. One of the loci studied, showed a positive association with both groups of patients. This locus lies in a region previously implicated in both disorders and contains a number of promising candidate genes.
A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene JS Brown Jr
Based on the similar geographical distribution of schizophrenia and tick-borne flaviviruses, a 'natural resistance gene' to flaviviruses, known as Flv in mice, was theorized to be present in some humans and cause other effects that lead to schizophrenia. One protein that may be the product of the gene is 'translation elongation factor ␣-1' (EF-1). The protein appears to inhibit the synthesis of viral proteins rather than cause an immune reaction. The current study theorized that EF-1 might 'misrecognize' and inhibit the production of normal human proteins. To test the theory, a comparison was made between the amino acid sequences of EF-1, certain portions of flaviviruses involved with EF-1, and proteins thought to be abnormal in schizophrenia. The comparisons were similar enough that the author recommends screening for Flv or its product in persons with schizophrenia.
Dopa decarboxylase genotypes may influence age at onset of schizophrenia AD Børglum, M Hampson, TE Kjeldsen et al
Several lines of evidence implicate dopa decarboxylase (DDC) with schizophrenia. By analysis of two putative functional DDC variants in 173 schizophrenic patients and 204 controls the authors tested the hypotheses that DDC is involved in: (1) predisposition to schizophrenia; and (2) modulation of age at disease onset. No association was observed to schizophrenia as a whole, whereas an association between DDC genotypes and age at disease onset was suggested in males. Both variants seemed to influence age at onset but in opposite Molecular Psychiatry directions, suggesting an additive model where one variant mediates early and the other late onset. The difference in mean age at onset between male patients with 'early' genotypes vs patients with 'late' genotypes was close to 5 years (95% CI: 0.7-8.8). Thus, DDC may possibly act as a modulator of age at onset in male schizophrenics. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects JK Rybakowski, A Borkowska, P M Czerski, J Hauser Altered dopamine neurotransmission and eye movement disturbances have been implicated in the pathogenic process of schizophrenia. Eye movement disturbances occur in a majority of patients with schizophrenia and in a proportion of their first-degree relatives and they have been suggested as a phenotypic marker in genetic studies of this illness. The authors found an association between the Ser9Gly polymorphism of DRD3 gene and eye movement disturbances (fixation and smooth pursuit) both in schizophrenic patients and in healthy control subjects where allele 1 (serine) was associated with the higher intensity of such disturbances. It is suggested that DRD3 Ser9Gly polymorphism may be a contributory factor to the performance of eye movements used as a phenotypic marker of schizophrenia.
Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats HJ Lee, JW Kim, SV Yim et al Deficiencies in mother-infant relationship during infancy have been known to influence neonatal development and behavior. Such environmental shortcomings are thought to affect the vulnerability of the infant to certain neuropsychiatric disorders over its lifespan. Fluoxetine is often used for treating maternal separation-related mental disorders in children. The authors administrated fluoxetine to rat pups with maternal separation and social isolation to determine its effects on neuronal development, in particular with respect to cell proliferation and apoptosis in the dentate gyrus of the hippocampus. Compared to pups with maternal separation without fluoxetine treatment, pups with maternal separation and fluoxetine treatment showed a significantly increased number of BrdU-positive cells and a significantly decreased number of TUNEL-positive cells in the dentate gyrus. These data support that fluoxetine affects cell proliferation and apoptosis and that it may offer new therapeutic opportunities as an agent to counteract the effects of maternal separation.
